Carlos R Figueiredo
9PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 22, 2024
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity.Miriam Langguth, Eleftheria Maranou, Saara A Koskela
|Sep 19, 2023
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptides.Saara A Koskela, Carlos R Figueiredo
|Jul 15, 2023
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities.Mona Meng Wang, Sarah E Coupland, Tero Aittokallio
|Feb 24, 2023
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities.Maisoon Matareed, Eleftheria Maranou, Saara A Koskela
|Jan 22, 2020
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.Carlos R Figueiredo, Helen Kalirai, Joseph J Sacco
Pageof 2
Frequent Collaborators
2 joint publications
Sarah E Coupland
2 joint publications
Eleftheria Maranou
2 joint publications
Mona Meng Wang
1 joint publications
Helen Kalirai
1 joint publications
Joseph R Slupsky
1 joint publications
Judy M Coulson
1 joint publications
Tero Aittokallio
1 joint publications
Oskar Elenius
1 joint publications
Roosa E Kallionpää
1 joint publications
Otto I Pulkkinen
